Literature DB >> 22683413

Therapeutic window of taurine against experimental stroke in rats.

Ming Sun1, Yu-Mei Zhao, Yi Gu, Chao Xu.   

Abstract

The dose-dependent protection of taurine against experimental stroke has been demonstrated previously. The objective of this study was to investigate the therapeutic window of taurine against experimental stroke, and the effects of delayed administration of taurine on inflammatory reaction in a rat model of stroke. Rats received 2-h ischemia by intraluminal filament, and then reperfused. Taurine (50 mg/kg) was administered intravenously 4 h, 8 h, 10 h, or 12 h after ischemia. The neurologic scores and the infarct volumes were evaluated 24 h after ischemia. Then, the effect of administration of taurine at 8 h after ischemia on the neutrophil infiltration in ischemic region was determined. Treatment with taurine 4 h or 8 h after ischemia significantly improved the neurologic function, and decreased the infarct volumes 24 h after ischemia. However, administration of taurine at 10 h or 12 h after ischemia had no significant neuroprotection. Further, taurine administered at 8 h after ischemia markedly reduced myeloperoxidase activity and attenuated neutrophil infiltration in ischemic region. Our data suggest that the therapeutic window of taurine against experimental stroke is of at least 8 h, and suppressing the neutrophil infiltration may be one of the mechanisms of delayed administration of taurine against experimental stroke.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22683413     DOI: 10.1016/j.trsl.2012.02.007

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  8 in total

1.  Anti-Inflammatory Effect of Taurine in Burned Patients.

Authors:  Sima Lak; Alireza Ostadrahimi; Behrooz Nagili; Mohammad Asghari-Jafarabadi; Sanaz Beigzali; Feridoon Salehi; Roxana Djafarzadeh
Journal:  Adv Pharm Bull       Date:  2015-11-30

2.  Effect of taurine on intestinal recovery following intestinal ischemia-reperfusion injury in a rat.

Authors:  I Sukhotnik; I Aranovich; Y Ben Shahar; N Bitterman; Y Pollak; D Berkowitz; D Chepurov; A G Coran; A Bitterman
Journal:  Pediatr Surg Int       Date:  2015-10-26       Impact factor: 1.827

3.  Neuroprotective Mechanisms of Taurine against Ischemic Stroke.

Authors:  Janet Menzie; Howard Prentice; Jang-Yen Wu
Journal:  Brain Sci       Date:  2013-06-03

Review 4.  Taurine as an Essential Neuromodulator during Perinatal Cortical Development.

Authors:  Werner Kilb; Atsuo Fukuda
Journal:  Front Cell Neurosci       Date:  2017-10-24       Impact factor: 5.505

5.  Effect of 3-Aminobenzamide on the Ultrastructure of Astrocytes and Microvessels After Focal Cerebral Ischemia in Rats.

Authors:  Jinqiao Wang; Chunyan Ma; Jing Zhu; Gaofeng Rao; Hongjuan Li
Journal:  Dose Response       Date:  2020-01-22       Impact factor: 2.658

Review 6.  Taurine and Its Derivatives: Analysis of the Inhibitory Effect on Platelet Function and Their Antithrombotic Potential.

Authors:  Adrian Eugen Roşca; Ana-Maria Vlădăreanu; Radu Mirica; Cristina-Mihaela Anghel-Timaru; Alina Mititelu; Bogdan Ovidiu Popescu; Constantin Căruntu; Suzana Elena Voiculescu; Şerban Gologan; Minodora Onisâi; Iuliana Iordan; Leon Zăgrean
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

7.  Protective Effects of 28-O-Caffeoyl Betulin (B-CA) on the Cerebral Cortex of Ischemic Rats Revealed by a NMR-Based Metabolomics Analysis.

Authors:  Xia Liu; Zhi Ruan; Xing-Cheng Shao; Hong-Xuan Feng; Lei Wu; Wei Wang; Hong-Min Wang; Hong-Yan Mu; Ru-Jun Zhang; Wei-Min Zhao; Hai-Yan Zhang; Nai-Xia Zhang
Journal:  Neurochem Res       Date:  2021-01-03       Impact factor: 3.996

8.  Lactulose Improves Neurological Outcomes by Repressing Harmful Bacteria and Regulating Inflammatory Reactions in Mice After Stroke.

Authors:  Quan Yuan; Ling Xin; Song Han; Yue Su; Ruixia Wu; Xiaoxuan Liu; Jimusi Wuri; Ran Li; Tao Yan
Journal:  Front Cell Infect Microbiol       Date:  2021-07-13       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.